Brief: Cti Biopharma Corp - Received Letter Stating Co Not In Compliance With Nasdaq Listing Rule
22/04/2020 22:22
April 22 (Reuters) - CTI Biopharma Corp CTIC.O :
* CTI BIOPHARMA CORP - ON APRIL 17, RECEIVED LETTER STATING
CO NOT
IN COMPLIANCE WITH NASDAQ LISTING RULE
Source text for Eikon: https://bit.ly/3cDfxj2
Further company coverage: CTIC.O
((Briefs@thomsonreuters.com;))
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners